Original document(5 pages)  中文版
    Method for obtaining an anti-tumor substance from even-toe hoofed mammals (artio-dactylous animals) having leucosis, and according to a first alternative, the substance is obtained from the lipid-free blood plasma fraction of the animal, and the blood is taken from a pregnant female donor animal being in the 2nd or 3rd period of pregnancy up to at most the beginning of the first week preceding delivery. According to a second alternative the substance is obtained from the colostrum of the female donor animal, being preferably cow or sheep.
Application Number
申请号
03802264 Application Date
申请日
2003.01.15
Title 名称 Method for obtaining an anti-tumor substance from even-toe hoofed mammals
Publication Number
公开号
1615142 Publication Date
公开日
2005.05.11
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K35/16;A61K35/20
Applicant(s) Name
申请人
Bertha Andras
Address 地址
Inventor(s) Name 发明人 Bertha Andras
Attorney & Agent 代理人 huang gesheng lin bainan

  
Pharmaceutical product for treatment and diagnosis of tumors and method for preparation of liqid free fraction of blood plasma
Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
A composition for treating neurocerebrovascular disorders
Lower alcohol-insoluble extract of hovenia dulcis thunb and a polysaccharide isolated therefrom
Ginger extract preparation
Treatment of glioblastoma with thymosin-alpha 1
Methods and compositions for derepression of IAP-inhibited caspase
Drug mobilizing pluripotent stem cells from tissue into peripheral blood
Assay for the detection of factors that modulate the expression of INGAP
Plasmid mediated suplementation for treating chronically ill subjects
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.